美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lineage

40.71

-1.0600-2.54%

盘前：40.00-0.7100-1.74%05:11 EDT

成交量：238.46万

成交额：9,748.16万

市值：93.13亿

市盈率：-15.38

高：42.67

开：41.50

低：40.58

收：41.77

52周最高：86.03

52周最低：38.83

股本：2.29亿

流通股本：5,764.28万

量比：2.72

换手率：4.14%

股息：1.96

股息率：4.82%

每股收益(TTM):-2.6473

每股收益(LYR):-3.6963

净资产收益率：-8.17%

总资产收益率：0.36%

市净率：1.08

市盈率(LYR):-11.01

数据加载中...

总览公司新闻公告

Capybobo东京首秀，PYBOBO限量皮肤娃衣受热捧

Lineage与新奥尔良港合作扩建保税仓储空间，助力全球贸易流通

Capybobo亮相WebX 2025，发布Web3原生潮玩IP娃衣

8月14日中船集团广船国际联合中船贸易为韩国H-LINE航运公司建造的8600车双燃料汽车运输船（PCTC）2号船签字交

Lineage Cell Therapeutics, Inc.盘中异动股价大涨6.66%报1.050美元

背景资料-热还是不热？近期备受瞩目的美国首次公开募股表现如何

Lineage Cell Therapeutics, Inc.盘中异动快速上涨5.26%

Lineage Inc 报告截至 6 月 30 日的季度业绩 - 收益摘要

韩国船企联合开发AI自主与环保船舶技术

国际船舶网

Lineage Inc 预计每股亏损5美分 - 财报前瞻

Lineage Cell Therapeutics, Inc.盘中异动临近收盘急速跳水5.25%

Lineage Cell Therapeutics, Inc.盘中异动临近收盘快速跳水6.07%

Lineage Cell Therapeutics, Inc.盘中异动股价大涨5.31%报1.19美元

Lineage Cell Therapeutics, Inc.盘中异动快速拉升5.56%

台湾Line Pay Money将成为独立支付应用

移动支付网

CStar Line开通连接中国与红海的新航线FRS1

Lineage Cell Therapeutics, Inc.盘中异动临近收盘急速下跌5.51%

Lineage Cell Therapeutics, Inc.盘中异动股价大涨5.34%

Lineage Cell Therapeutics, Inc.盘中异动下午盘大幅跳水5.19%报1.01美元

Lineage Cell Therapeutics, Inc.盘中异动早盘大幅上涨5.51%报1.039美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LINE/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LINE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":40.71,"timestamp":1756238400000,"preClose":41.77,"halted":0,"volume":2384610,"hourTrading":{"tag":"盘前","latestPrice":40,"preClose":40.71,"latestTime":"05:11 EDT","volume":2,"amount":81.29,"timestamp":1756285900062},"delay":0,"floatShares":57642784,"shares":228767627,"eps":-2.647321,"marketStatus":"盘前交易","change":-1.06,"latestTime":"08-27 07:18:15 EDT","open":41.5,"high":42.665,"low":40.5849,"amount":97481631.11046,"amplitude":0.049799,"askPrice":41.29,"askSize":23,"bidPrice":40.11,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-2.647321,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756301400000},"marketStatusCode":1,"adr":0,"listingDate":1721880000000,"exchange":"NASDAQ","adjPreClose":40.71,"dividendRate":0.048207,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40.71,"latestTime":"05:11 EDT","volume":2,"amount":81.29,"timestamp":1756285900062},"postHourTrading":{"tag":"盘后","latestPrice":41.52,"preClose":40.71,"latestTime":"17:33 EDT","volume":267008,"amount":10870280.2404,"timestamp":1756244015117},"volumeRatio":2.7153744804899644,"impliedVol":0.3929,"impliedVolPercentile":0.6827},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LINE\",,,,,undefined,":{"symbol":"LINE","floatShares":57642784,"roa":"0.36%","roe":"-8.17%","lyrEps":-3.696335,"volumeRatio":2.7153744804899644,"shares":228767627,"dividePrice":1.9625,"high":42.665,"amplitude":0.049799,"preClose":41.77,"low":40.5849,"week52Low":38.83,"pbRate":"1.08","psRate":"1.75","week52High":86.03,"institutionHeld":0.1784,"latestPrice":40.71,"committee":0.021277,"eps":-2.647321,"divideRate":0.048207,"volume":2384610,"delay":0,"ttmEps":-2.647321,"open":41.5,"prevYearClose":58.57,"prevWeekClose":40.28,"prevMonthClose":43.15,"prevQuarterClose":43.52,"fiveDayClose":40.02,"twentyDayClose":44.08,"sixtyDayClose":42.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LINE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-06","symbol":"LINE","fiscalQuarterEnding":"2025/06","expectedEps":0.62,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":0.81},{"date":"2025-06-30","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-30","defaultRemindTime":1751290200000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-21","payableDate":"2025-06-30","currency":"USD","dateTimestamp":1751256000000,"payDate":"2025-07-21"},{"market":"US","date":"2025-04-30","symbol":"LINE","fiscalQuarterEnding":"2025/03","expectedEps":0.67,"name":null,"time":"盘前","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"pre","actualEps":0.86},{"date":"2025-03-31","symbol":"LINE","amount":0.5275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-31","defaultRemindTime":1743427800000,"name":"Lineage","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-21","payableDate":"2025-03-31","currency":"USD","dateTimestamp":1743393600000,"payDate":"2025-04-21"},{"market":"US","date":"2025-02-26","symbol":"LINE","fiscalQuarterEnding":"2024/12","expectedEps":0.68,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"pre","actualEps":0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LINE\",market:\"US\",,,undefined,":[{"executeDate":"2024-09-30","recordDate":"2024-09-30","paymentDate":"2024-10-21","value":0.38,"currency":"USD"},{"executeDate":"2024-12-31","recordDate":"2024-12-31","paymentDate":"2025-01-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-03-31","recordDate":"2025-03-31","paymentDate":"2025-04-21","value":0.5275,"currency":"USD"},{"executeDate":"2025-06-30","recordDate":"2025-06-30","paymentDate":"2025-07-21","value":0.5275,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LINE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0526,"buy":0.3158,"hold":0.4737,"sell":0.1579,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4737,"analysts":19,"updateTime":1754971200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LINE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LINE","date":"2025-08-26","current":-17.002889,"percent":0.737226,"low":-150.19606,"twenty":-88.285736,"median":-20.615045,"eighty":-16.561064,"high":-14.964597,"avg":-42.532414,"sd":40.573514,"marketCap":9555623779},"quantilePoints":[{"date":"2024-07-26","current":-135.297148,"twenty":-133.240266,"median":-129.59991,"eighty":-127.33081,"marketCap":18224525800},{"date":"2024-08-02","current":-145.820923,"twenty":-146.760391,"median":-140.374056,"eighty":-130.053731,"marketCap":19642078377},{"date":"2024-08-09","current":-149.178586,"twenty":-148.252685,"median":-145.575034,"eighty":-133.925893,"marketCap":20094355563},{"date":"2024-08-16","current":-142.403908,"twenty":-146.770565,"median":-143.819892,"eighty":-138.343293,"marketCap":19181806393},{"date":"2024-08-23","current":-98.688122,"twenty":-146.923186,"median":-143.404424,"eighty":-130.053731,"marketCap":19540248095},{"date":"2024-08-30","current":-96.480231,"twenty":-146.227913,"median":-142.463261,"eighty":-98.833015,"marketCap":19103085705},{"date":"2024-09-06","current":-93.156895,"twenty":-146.119382,"median":-140.374056,"eighty":-96.954008,"marketCap":18445065232},{"date":"2024-09-13","current":-95.732768,"twenty":-145.993894,"median":-129.59991,"eighty":-95.649972,"marketCap":18955088021},{"date":"2024-09-20","current":-93.087899,"twenty":-145.732742,"median":-99.424085,"eighty":-94.909408,"marketCap":18431403907},{"date":"2024-09-27","current":-90.02905,"twenty":-145.49194,"median":-98.486882,"eighty":-94.26544,"marketCap":17825751846},{"date":"2024-10-04","current":-88.39613,"twenty":-144.725443,"median":-96.871212,"eighty":-93.115497,"marketCap":17502433828},{"date":"2024-10-11","current":-86.556221,"twenty":-143.487517,"median":-95.865011,"eighty":-90.408531,"marketCap":17138131836},{"date":"2024-10-18","current":-89.178092,"twenty":-142.853292,"median":-95.28429,"eighty":-88.708915,"marketCap":17657262174},{"date":"2024-10-25","current":-87.671666,"twenty":-142.575183,"median":-94.927808,"eighty":-88.455927,"marketCap":17358989918},{"date":"2024-11-01","current":-83.106392,"twenty":-142.43952,"median":-94.755316,"eighty":-88.014349,"marketCap":16455065601},{"date":"2024-11-08","current":-23.853641,"twenty":-141.591967,"median":-94.082599,"eighty":-87.618769,"marketCap":15361744673},{"date":"2024-11-15","current":-22.510722,"twenty":-138.343293,"median":-93.156895,"eighty":-86.629817,"marketCap":14496904918},{"date":"2024-11-22","current":-22.712691,"twenty":-133.925893,"median":-92.24269,"eighty":-85.252186,"marketCap":14626973166},{"date":"2024-11-29","current":-22.471745,"twenty":-130.961371,"median":-90.805262,"eighty":-83.56407,"marketCap":14471804028},{"date":"2024-12-06","current":-22.011114,"twenty":-127.33081,"median":-90.02905,"eighty":-23.887657,"marketCap":14175157147},{"date":"2024-12-13","current":-21.97568,"twenty":-121.749465,"median":-89.580572,"eighty":-23.012456,"marketCap":14152338156},{"date":"2024-12-20","current":-20.753234,"twenty":-99.32519,"median":-88.545623,"eighty":-22.64466,"marketCap":13365082970},{"date":"2024-12-27","current":-20.905597,"twenty":-98.92961,"median":-88.258137,"eighty":-22.510722,"marketCap":13463204631},{"date":"2025-01-03","current":-20.905597,"twenty":-98.73642,"median":-88.20064,"eighty":-22.420722,"marketCap":13463204631},{"date":"2025-01-10","current":-19.654805,"twenty":-98.446634,"median":-87.890155,"eighty":-22.273319,"marketCap":12657694252},{"date":"2025-01-17","current":-20.615045,"twenty":-97.561177,"median":-87.625669,"eighty":-22.140799,"marketCap":13276088905},{"date":"2025-01-24","current":-21.245756,"twenty":-96.995405,"median":-87.407179,"eighty":-21.811979,"marketCap":13682266943},{"date":"2025-01-31","current":-21.259929,"twenty":-96.71482,"median":-86.556221,"eighty":-21.261347,"marketCap":13691394540},{"date":"2025-02-07","current":-20.522919,"twenty":-96.287041,"median":-85.872006,"eighty":-21.229457,"marketCap":13216759529},{"date":"2025-02-14","current":-19.973704,"twenty":-95.89146,"median":-85.084294,"eighty":-20.979298,"marketCap":12863065170},{"date":"2025-02-21","current":-19.091417,"twenty":-95.705169,"median":-83.416877,"eighty":-20.860243,"marketCap":12294872296},{"date":"2025-02-28","current":-20.706163,"twenty":-95.532678,"median":-24.073327,"eighty":-20.758903,"marketCap":13748892325},{"date":"2025-03-07","current":-21.053271,"twenty":-95.272791,"median":-23.651671,"eighty":-20.753234,"marketCap":13979371682},{"date":"2025-03-14","current":-20.118486,"twenty":-95.185395,"median":-23.100685,"eighty":-20.713451,"marketCap":13358674800},{"date":"2025-03-21","current":-20.070372,"twenty":-94.983005,"median":-22.840251,"eighty":-20.684293,"marketCap":13326727167},{"date":"2025-03-28","current":-20.269701,"twenty":-94.831212,"median":-22.58336,"eighty":-20.618588,"marketCap":13459081649},{"date":"2025-04-04","current":-18.678506,"twenty":-94.801314,"median":-22.510722,"eighty":-20.546012,"marketCap":12402527766},{"date":"2025-04-11","current":-18.45512,"twenty":-94.693219,"median":-22.452257,"eighty":-20.399959,"marketCap":12254199467},{"date":"2025-04-17","current":-19.214632,"twenty":-94.444831,"median":-22.33887,"eighty":-20.283448,"marketCap":12758515683},{"date":"2025-04-25","current":-19.194012,"twenty":-94.145846,"median":-22.252059,"eighty":-20.149417,"marketCap":12744823840},{"date":"2025-05-02","current":-16.587441,"twenty":-94.019352,"median":-22.179422,"eighty":-20.037483,"marketCap":10350562942},{"date":"2025-05-09","current":-16.711993,"twenty":-93.904358,"median":-22.011114,"eighty":-19.920554,"marketCap":10428283601},{"date":"2025-05-16","current":-17.448317,"twenty":-93.156895,"median":-21.581486,"eighty":-19.676065,"marketCap":10887749844},{"date":"2025-05-23","current":-16.71932,"twenty":-93.087899,"median":-21.263473,"eighty":-19.558303,"marketCap":10432855404},{"date":"2025-05-30","current":-16.092895,"twenty":-92.811913,"median":-21.249299,"eighty":-19.409177,"marketCap":10041966212},{"date":"2025-06-06","current":-16.096558,"twenty":-91.942555,"median":-21.231583,"eighty":-19.343951,"marketCap":10044252113},{"date":"2025-06-13","current":-16.646053,"twenty":-91.006502,"median":-21.199693,"eighty":-19.183414,"marketCap":10387137370},{"date":"2025-06-20","current":-16.320019,"twenty":-90.801812,"median":-21.08985,"eighty":-19.019731,"marketCap":10183692118},{"date":"2025-06-27","current":-16.429919,"twenty":-90.394732,"median":-20.934756,"eighty":-18.674382,"marketCap":10252269169},{"date":"2025-07-03","current":-15.946362,"twenty":-90.091147,"median":-20.886643,"eighty":-18.14994,"marketCap":9950530143},{"date":"2025-07-11","current":-15.77785,"twenty":-90.01985,"median":-20.860815,"eighty":-17.486415,"marketCap":9845378664},{"date":"2025-07-18","current":-15.191722,"twenty":-89.932455,"median":-20.808156,"eighty":-17.309844,"marketCap":9479634391},{"date":"2025-07-25","current":-15.847453,"twenty":-89.62887,"median":-20.753234,"eighty":-16.815894,"marketCap":9888810797},{"date":"2025-08-01","current":-15.807157,"twenty":-89.274687,"median":-20.746147,"eighty":-16.701003,"marketCap":9863665878},{"date":"2025-08-08","current":-17.422161,"twenty":-88.925104,"median":-20.723347,"eighty":-16.650449,"marketCap":9791254435},{"date":"2025-08-15","current":-16.376017,"twenty":-88.485826,"median":-20.675311,"eighty":-16.612351,"marketCap":9203321634},{"date":"2025-08-22","current":-15.911969,"twenty":-88.340933,"median":-20.632761,"eighty":-16.564012,"marketCap":8942526539},{"date":"2025-08-26","current":-17.002889,"twenty":-88.285736,"median":-20.615045,"eighty":-16.561064,"marketCap":9555623779}],"updateTime":1756293493711},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LINE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561263948","title":"Capybobo东京首秀，PYBOBO限量皮肤娃衣受热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=2561263948","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561263948?lang=zh_cn&edition=fundamental","pubTime":"2025-08-24 20:23","pubTimestamp":1756038180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/308966","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK0231","BK4144","NEXT","LINE","300959","BK4224"],"gpt_icon":0},{"id":"1152457993","title":"Lineage与新奥尔良港合作扩建保税仓储空间，助力全球贸易流通","url":"https://stock-news.laohu8.com/highlight/detail?id=1152457993","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152457993?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 05:01","pubTimestamp":1755810076,"startTime":"0","endTime":"0","summary":"Lineage与新奥尔良港合作扩建保税仓储空间，助力全球贸易流通","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2560109347","title":"Capybobo亮相WebX 2025，发布Web3原生潮玩IP娃衣","url":"https://stock-news.laohu8.com/highlight/detail?id=2560109347","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560109347?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 21:10","pubTimestamp":1755695400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/308281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["NEXT","LU1487256676.USD","LINE","BK4585","BK4136","IE00B3T34201.USD","LU1481600234.SGD","LU2463526074.USD","BK4144","LU1481599808.USD","IP","BK4588","BK4224","LU1169589451.USD","LU1169590202.USD"],"gpt_icon":0},{"id":"2559960910","title":"8月14日中船集团广船国际联合中船贸易为韩国H-LINE航运公司建造的8600车双燃料汽车运输船（PCTC）2号船签字交","url":"https://stock-news.laohu8.com/highlight/detail?id=2559960910","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559960910?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 07:05","pubTimestamp":1755212737,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2558665056","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.66%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558665056?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 21:44","pubTimestamp":1754919856,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时44分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为2598.16%、259.43%、82.15%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为74.27%、69.75%、20.72%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","BK4539","BK4007","BK4224","LENZ","LCTX"],"gpt_icon":0},{"id":"2557560029","title":"背景资料-热还是不热？近期备受瞩目的美国首次公开募股表现如何","url":"https://stock-news.laohu8.com/highlight/detail?id=2557560029","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557560029?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 01:10","pubTimestamp":1754586605,"startTime":"0","endTime":"0","summary":"近期备受瞩目的美国首次公开募股表现如何根据最新进展改写了第 1-2 段，增加了 Figma、Firefly 和 Chime IPO 的条目；更新了图表和价格。股票市场的飙升和知名新股的强劲表现重新激发了人们对首次公开募股的热情。  首日开盘 股价上涨 59%，目前的交易价格比首次公开募股价格高出近 22%。该公司股票在  开盘时比首次公开募股价格低近 4%，在纽约证券交易所的首次公开募股中表现低迷。 的股价比首次公开募股价格低 11%，但自首次公开募股以来已上涨20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nL4S3TZ22V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2420271590.USD","WAY","CRCL","NVD2.UK","SNVD.UK","SAIL","LU2097344431.USD","LU1814569148.SGD","LU0882574139.USD","CHYM","LU2125909593.SGD","NVDS","CART","NVDD","BIRK","SARO","NVD3.UK","LINE","LU1923622291.USD","BK4167","LU0256863811.USD","VG","VIK","BK4554","LU0267386448.USD","LU2360107671.USD","NVDS.UK","NVIW.SI","3NVD.UK","LU0708994859.HKD","LU0238689110.USD","IE0034235188.USD","2NVD.UK","LU2249611893.SGD","LU0861579265.USD","LU1035775433.USD","LU2089985449.USD","NVDU","NVDX","NVDY","LU1496350502.SGD","NVD","NOC","LU2552382132.HKD","IE00BKVL7J92.USD","LU0689472784.USD"],"gpt_icon":1},{"id":"2557301828","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557301828?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 02:16","pubTimestamp":1754504164,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时16分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biomx Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Rigel Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为723.43%、604.52%、101.55%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Biomx Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为57.18%、51.84%、48.52%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LCTX","LENZ","BK4139","BK4224","BK4539","LINE"],"gpt_icon":0},{"id":"2557370774","title":"Lineage Inc 报告截至 6 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2557370774","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557370774?lang=zh_cn&edition=fundamental","pubTime":"2025-08-06 21:33","pubTimestamp":1754487180,"startTime":"0","endTime":"0","summary":"Lineage Inc 报告截至 6 月 30 日的季度业绩 - 收益摘要Lineage Inc LINE.OQ公布的截至6月30日的季度调整后每股亏损为8美分，高于去年同期的每股-46美分。Lineage Inc公布的本季度每股收益为亏损3美分。Lineage Inc本季度股价上涨了2.1%，今年迄今为止亏损了24.1%。华尔街对 Lineage Inc 的 12 个月目标价中位数为 51.00 美元，比上次收盘价 44.44 美元高出约 12.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nL4S3TY1EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2557352092","title":"韩国船企联合开发AI自主与环保船舶技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2557352092","media":"国际船舶网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557352092?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 13:23","pubTimestamp":1754371412,"startTime":"0","endTime":"0","summary":"近日，HD现代集团旗下的HD韩国造船海洋、HD现代海洋解决方案、Avikus与韩国船东H-Line签署四方战略合作协议。根据协议，四方将联合开发基于人工智能的自主与环保船舶技术，最大限度地提升船舶及船队运营的整体效率。HD韩国造船海洋未来技术研究院院长张光弼表示：“此次合作是打破造船与航运行业界限、推动基于AI的数字化创新的起点。这将成为引领环保未来船舶标准的重要里程碑。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132908a6d3c528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805132908a6d3c528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4504","BK4585","LU1674673428.USD","LU1093756168.USD","LU0942090050.USD","BK4550","LU2756315664.SGD","LU0820561818.USD","LU1496350171.SGD","LU0238689110.USD","BK4213","LU1035775433.USD","LU0820561909.HKD","LU0689472784.USD","BK4588","LU1551013425.SGD","BK4201","BK4224","LU0079474960.USD","LU1989772923.USD","LU1496350502.SGD","LU1551013342.USD","LU0354030438.USD","IE00B1XK9C88.USD","LU0868494617.USD","IE00BZ1G4Q59.USD","LU0354030511.USD","LU0823411888.USD","LU0823434583.USD","LU1162221912.USD","BK4581","BK4567","IE00BKVL7J92.USD","IE00BWXC8680.SGD","BK4534","LU1989772840.SGD","LU0234572021.USD","LINE","IMO","HD","LU0823434740.USD","IE00BSNM7G36.USD","BK4566","LU0868494708.USD","LU0943347566.SGD","LU1069344957.HKD","AR","LU1778281490.HKD","BK4533","LU1674673691.USD"],"gpt_icon":0},{"id":"2556938724","title":"Lineage Inc 预计每股亏损5美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2556938724","media":"路透中文","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556938724?lang=zh_cn&edition=fundamental","pubTime":"2025-08-04 22:13","pubTimestamp":1754316788,"startTime":"0","endTime":"0","summary":"Lineage Inc 预计每股亏损5美分 - 财报前瞻Lineage Inc LINE.OQ LINE.O将于8月6日公布截至2025年6月30日的财报，预计季度营收将出现下降。LSEG分析师对Lineage公司的平均预期为每股亏损5美分。华尔街对 Lineage 公司 12 个月目标价的中位数为 51.00 美元，比上次收盘价 42.35 美元高出约 17%。8月4日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL4S3TW1BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LINE"],"gpt_icon":0},{"id":"2556453228","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速跳水5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556453228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556453228?lang=zh_cn&edition=fundamental","pubTime":"2025-08-02 03:53","pubTimestamp":1754077998,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时53分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下跌5.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Equillium, Inc.、4D Molecular Therapeutics, Inc.、Sensei Biotherapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Equillium, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1785.52%、384.54%、308.60%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为253.15%、72.18%、59.20%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4224","BK4539","BK4007","BK4139","LCTX"],"gpt_icon":0},{"id":"2555099029","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘快速跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555099029?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 03:40","pubTimestamp":1753904441,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时40分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水6.07%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4224","BK4539","BK4007","LENZ","LINE","BK4139"],"gpt_icon":0},{"id":"2554341770","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554341770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554341770?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 22:19","pubTimestamp":1753712380,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时19分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.31%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为313.11%、160.72%、109.68%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为102.74%、75.82%、71.61%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","LCTX","BK4224","LENZ","LINE"],"gpt_icon":0},{"id":"2554782424","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782424?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 01:33","pubTimestamp":1753378435,"startTime":"0","endTime":"0","summary":"北京时间2025年07月25日01时33分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速拉升5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725013356a461b639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725013356a461b639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LCTX","LENZ","BK4007","BK4224","BK4539","BK4139"],"gpt_icon":0},{"id":"2553383852","title":"台湾Line Pay Money将成为独立支付应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2553383852","media":"移动支付网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553383852?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 15:26","pubTimestamp":1753169160,"startTime":"0","endTime":"0","summary":"台湾地区金融监督管理委员会已授权Line Pay Taiwan开发名为Line Pay Money的独立电子支付应用程序。FSC的代表还提到，Line Pay Money的实收资本约为1700万美元，将被允许提供小额境内汇款和忠诚度积分支付。此外，Line Pay于2025年2月提交了申请，并与中央银行进行了磋商，现已获得批准。随着Line Pay Money的授权，台湾将拥有10家专用电子支付机构和20家混合电子支付机构，包括银行和中华邮政。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722153730954c8a50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722153730954c8a50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2552455500","title":"CStar Line开通连接中国与红海的新航线FRS1","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455500","media":"华光源海","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552455500?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 09:12","pubTimestamp":1752801175,"startTime":"0","endTime":"0","summary":"CStar Line将开通连接中国与红海的新航线FRS1，7月26日首航。集运企业CStar Line将开通一条连接中国与红海的新航线FRS1，计划7月26日首航，首航船为1831TEU的“CSTAR VOYAGER”轮。媒体相关报道据了解，CStar Line总部位于迪拜，提供远东、印度、中东、地中海、黑海和波罗的海之间的集运服务，同时还提供多式联运解决方案。中国常驻联合国副代表耿爽也在会上表示，呼吁胡塞武装尊重各国商船，根据国际法在红海水域的航行权利，停止袭击商船，维护红海水域航道安全。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718102117a45248df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718102117a45248df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224"],"gpt_icon":0},{"id":"2551947061","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551947061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551947061?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 03:43","pubTimestamp":1752608634,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时43分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速下挫5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3810.84%、2220.11%、1568.97%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LINE","BK4224","LCTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2551844311","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551844311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551844311?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 21:49","pubTimestamp":1752500979,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时49分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.、Dare Bioscience, Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1731.80%、593.92%、459.18%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、100.99%、87.78%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LENZ","BK4139","LCTX","BK4539","LINE","BK4007"],"gpt_icon":0},{"id":"2550620982","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅跳水5.19%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550620982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550620982?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 01:18","pubTimestamp":1752167930,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日01时18分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pelthos Therapeutics Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为376.94%、345.08%、309.59%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为91.19%、90.07%、74.89%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","BK4539","BK4007","BK4224","LENZ","LCTX"],"gpt_icon":0},{"id":"2550656898","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.51%报1.039美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550656898?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 22:12","pubTimestamp":1752070374,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为830.79%、672.72%、495.57%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Calidi Biotherapeutics, Inc.、Prokidney Corp.，振幅分别为112.02%、104.48%、48.79%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","BK4224","LINE","BK4539","LCTX"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}]}}